These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 8906153)

  • 21. Blockade of ATP-sensitive K+ channels attenuates preconditioning effect on myocardial metabolism in swine: myocardial metabolism and ATP-sensitive K+ channels.
    Yokota R; Tanaka M; Yamasaki K; Araki M; Miyamae M; Maeda T; Koga K; Yabuuchi Y; Sasayama S
    Int J Cardiol; 1998 Dec; 67(3):225-36. PubMed ID: 9894703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid ventricular pacing produces myocardial protection by nonischemic activation of KATP+ channels.
    Koning MM; Gho BC; van Klaarwater E; Opstal RL; Duncker DJ; Verdouw PD
    Circulation; 1996 Jan; 93(1):178-86. PubMed ID: 8616925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pronounced antiarrhythmic effects of ischemic preconditioning.
    Parratt J; Vegh A
    Cardioscience; 1994 Mar; 5(1):9-18. PubMed ID: 8204800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardioprotective Effects of Mitochondria-Targeted Peptide SBT-20 in two Different Models of Rat Ischemia/Reperfusion.
    Dai W; Cheung E; Alleman RJ; Perry JB; Allen ME; Brown DA; Kloner RA
    Cardiovasc Drugs Ther; 2016 Dec; 30(6):559-566. PubMed ID: 27747447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal ischemia/reperfusion remotely improves myocardial energy metabolism during myocardial ischemia via adenosine receptors in rabbits: effects of "remote preconditioning".
    Takaoka A; Nakae I; Mitsunami K; Yabe T; Morikawa S; Inubushi T; Kinoshita M
    J Am Coll Cardiol; 1999 Feb; 33(2):556-64. PubMed ID: 9973039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mast cell degranulation does not contribute to ischemic preconditioning in isolated rabbit hearts.
    Wang P; Downey JM; Cohen MV
    Basic Res Cardiol; 1996; 91(6):458-67. PubMed ID: 8996631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissociation between anti-infarct effect and anti-edema effect of ischemic preconditioning.
    Sanz E; García Dorado D; Oliveras J; Barrabés JA; Gonzalez MA; Ruiz-Meana M; Solares J; Carreras MJ; García-Lafuente A; Desco M
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H233-41. PubMed ID: 7840267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ischaemic preconditioning by partial occlusion without intermittent reperfusion.
    Koning MM; Simonis LA; de Zeeuw S; Nieukoop S; Post S; Verdouw PD
    Cardiovasc Res; 1994 Aug; 28(8):1146-51. PubMed ID: 7954615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular pharmacology of the adenosine A1/A2-receptor agonist AMP 579: coronary hemodynamic and cardioprotective effects in the canine myocardium.
    McVey MJ; Smits GJ; Cox BF; Kitzen JM; Clark KL; Perrone MH
    J Cardiovasc Pharmacol; 1999 May; 33(5):703-10. PubMed ID: 10226856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of the time period between preconditioning ischemia and prolonged ischemia on myocardial protection.
    Alkhulaifi AM; Pugsley WB; Yellon DM
    Cardioscience; 1993 Sep; 4(3):163-9. PubMed ID: 8400024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preconditioning ischemia time determines the degree of glycogen depletion and infarct size reduction in rat hearts.
    Barbosa V; Sievers RE; Zaugg CE; Wolfe CL
    Am Heart J; 1996 Feb; 131(2):224-30. PubMed ID: 8579012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway.
    Vegh A; Szekeres L; Parratt J
    Br J Pharmacol; 1992 Nov; 107(3):648-52. PubMed ID: 1472963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypothermia increases the threshold for ischemic preconditioning.
    Dote K; Wolff RA; Van Winkle DM
    J Thorac Cardiovasc Surg; 1998 Aug; 116(2):319-26. PubMed ID: 9699586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endotoxin induces a second window of protection in the rat heart as determined by using p-nitro-blue tetrazolium staining, cardiac troponin T release, and histology.
    Zacharowski K; Otto M; Hafner G; Chatterjee PK; Thiemermann C
    Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2276-80. PubMed ID: 10479673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardioprotection associated with preconditioning in the anesthetized ferret.
    Gomoll AW
    Basic Res Cardiol; 1996; 91(6):433-43. PubMed ID: 8996628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraischemic preconditioning. Increased tolerance to sustained low-flow ischemia by a brief episode of no-flow ischemia without intermittent reperfusion.
    Schulz R; Post H; Sakka S; Wallbridge DR; Heusch G
    Circ Res; 1995 Jun; 76(6):942-50. PubMed ID: 7758165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The early and late phases of ischemic preconditioning: a comparative analysis of their effects on infarct size, myocardial stunning, and arrhythmias in conscious pigs undergoing a 40-minute coronary occlusion.
    Qiu Y; Tang XL; Park SW; Sun JZ; Kalya A; Bolli R
    Circ Res; 1997 May; 80(5):730-42. PubMed ID: 9130454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit.
    Birnbaum Y; Hale SL; Kloner RA
    Circulation; 1997 Sep; 96(5):1641-6. PubMed ID: 9315559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.
    Murry CE; Jennings RB; Reimer KA
    Circulation; 1986 Nov; 74(5):1124-36. PubMed ID: 3769170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of propranolol on ischemic myocardial damage and left ventricular hypertrophy following permanent coronary artery occlusion or occlusion followed by reperfusion.
    Smith EF; Egan JW; Griswold DE
    Pharmacology; 1989; 38(5):298-309. PubMed ID: 2527373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.